Journal article
Lamotrigine Therapy for Bipolar Depression: Analysis of Self-Reported Patient Data
- Abstract:
-
BACKGROUND:Depression in people with bipolar disorder is a major cause of long-term disability, possibly leading to early mortality and currently, limited safe and effective therapies exist. Although existing monotherapies such as quetiapine have limited proven efficacy and practical tolerability, treatment combinations may lead to improved outcomes. Lamotrigine is an anticonvulsant currently licensed for the prevention of depressive relapses in individuals with bipolar disorder. A double-bli...
Expand abstract
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Authors
Bibliographic Details
- Publisher:
- JMIR Publications Publisher's website
- Journal:
- JMIR Mental Health Journal website
- Volume:
- 5
- Issue:
- 4
- Pages:
- e63
- Publication date:
- 2018-11-22
- Acceptance date:
- 2018-06-17
- DOI:
- EISSN:
-
2368-7959
- Pmid:
-
30467104
Item Description
- Language:
- English
- Keywords:
- Pubs id:
-
pubs:948997
- UUID:
-
uuid:38fbdca0-52f3-46b4-ac87-1bf309b46aa0
- Local pid:
- pubs:948997
- Source identifiers:
-
948997
- Deposit date:
- 2019-05-03
Terms of use
- Copyright holder:
- Nzeyimana, A et al
- Copyright date:
- 2018
- Notes:
- © Antoine Nzeyimana, Kate EA Saunders, John R Geddes, Patrick E McSharry. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in JMIR Mental Health, is properly cited. The complete bibliographic information, a link to the original publication on http://mental.jmir.org/, as well as this copyright and license information must be included.
- Licence:
- CC Attribution (CC BY)
Metrics
If you are the owner of this record, you can report an update to it here: Report update to this record